EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-Cell Network-Based Drug Repositioning for Discovery of Therapies against Anti-Tumour Necrosis Factor-Resistant Crohn’s Disease

Min Seob Kwak iD, Chang-Il Hwang iD, Jae Myung Cha, Jung Won Jeon, Jin Young Yoon, Su Bee Park

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241814099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Min Seob Kwak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul 05278, Republic of Korea. Hauptthemen laut MEDLINE: Crohn Disease, Drug Repositioning, Single-Cell Analysis, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary and secondary non-response affects approximately 50% of patients with Crohn’s disease treated with anti-tumour necrosis factor (TNF) monoclonal antibodies. To date, very little single cell research exists regarding drug repurposing in Crohn’s disease. We aimed to elucidate the cellular phenomena underlying resistance to anti-TNF therapy in patients with Crohn’s disease and to identify potential drug candidates for these patients. Single-cell transcriptome analyses were performed using data (GSE134809) from the Gene Expression Omnibus and Library of Integrated Network-Based Cellular Signatures L1000 Project. Data aligned to the Genome Reference Consortium Human Build 38 reference genome using the Cell Ranger software were processed using the Seurat package. To capture significant functional terms, gene ontology functional enrichment analysis was performed on the marker genes. For biological analysis, 93,893 cells were retained (median 20,163 genes). Through marker genes, seven major cell lineages were identified: B-cells, T-cells, natural killer cells, monocytes, endothelial cells, epithelial cells, and tissue stem cells. In the anti-TNF-resistant samples, the top 10 differentially expressed genes were HLA-DQB-1, IGHG1, RPS23, RPL7A, ARID5B, LTB, STAT1, NAMPT, COTL1, ISG20, IGHA1, IGKC, and JCHAIN, which were robustly distributed in all cell lineages, mainly in B-cells. Through molecular function analyses, we found that the biological functions of both monocyte and T-cell groups mainly involved immune-mediated functions. According to multi-cluster drug repurposing prediction, vorinostat is the top drug candidate for patients with anti-TNF-refractory Crohn’s disease. Differences in cell populations and immune-related activity within tissues may influence the responsiveness of Crohn’s disease to anti-TNF agents. Vorinostat may serve as a promising novel therapy for anti-TNF-resistant Crohn’s disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseDrug RepositioningSingle-Cell AnalysisTumor Necrosis Factor-alphaDrug ResistanceHumansGene Expression ProfilingTranscriptomeGene Regulatory Networks

Stichwörter der Autor:innen

Crohn’s diseaseanti-TNFdrug repositioningrefractory diseasesingle cell sequencing

Substanzen

Tumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul 05278, Republic of Korea.
  • Department of Microbiology and Molecular Genetics, College of Biological Sciences, University of California Davis, Davis, CA 95616, USA.

ORCID-Profile: Min Seob Kwak, Chang-Il Hwang

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Kwak, M. S., Hwang, C. I., Cha, J. M., Jeon, J. W., Yoon, J. Y., & Park, S. B. (2023). Single-Cell Network-Based Drug Repositioning for Discovery of Therapies against Anti-Tumour Necrosis Factor-Resistant Crohn’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241814099

Vancouver

Kwak MS, Hwang CI, Cha JM, Jeon JW, Yoon JY, Park SB. Single-Cell Network-Based Drug Repositioning for Discovery of Therapies against Anti-Tumour Necrosis Factor-Resistant Crohn’s Disease. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241814099

BibTeX
@article{Kwak2023,
  author = {Kwak, Min Seob and Hwang, Chang-Il and Cha, Jae Myung and Jeon, Jung Won and Yoon, Jin Young and Park, Su Bee},
  title = {Single-Cell Network-Based Drug Repositioning for Discovery of Therapies against Anti-Tumour Necrosis Factor-Resistant Crohn’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241814099}
}
Kostenlos starten →